This agreement builds on Bristol-Myers' long-standing commitment to the global fight against AIDS. In Sub-Saharan Africa, where the HIV/AIDS pandemic has been especially devastating, we've taken a broad-based approach to addressing the AIDS crisis, including providing our AIDS medicines at no profit prices and committing to ensure our patents do not prevent inexpensive treatment in the region.
| |